Ryapolova, A.; Minskaia, E.; Gasanov, N.; Moroz, V.; Krapivin, B.; Egorov, A.D.; Laktyushkin, V.; Zhuravleva, S.; Nagornych, M.; Subcheva, E.;
et al. Development of Recombinant Oncolytic rVSV-mIL12-mGMCSF for Cancer Immunotherapy. Int. J. Mol. Sci. 2024, 25, 211.
https://doi.org/10.3390/ijms25010211
AMA Style
Ryapolova A, Minskaia E, Gasanov N, Moroz V, Krapivin B, Egorov AD, Laktyushkin V, Zhuravleva S, Nagornych M, Subcheva E,
et al. Development of Recombinant Oncolytic rVSV-mIL12-mGMCSF for Cancer Immunotherapy. International Journal of Molecular Sciences. 2024; 25(1):211.
https://doi.org/10.3390/ijms25010211
Chicago/Turabian Style
Ryapolova, Anastasia, Ekaterina Minskaia, Nizami Gasanov, Vasiliy Moroz, Bogdan Krapivin, Alexander D. Egorov, Victor Laktyushkin, Sofia Zhuravleva, Maksim Nagornych, Elena Subcheva,
and et al. 2024. "Development of Recombinant Oncolytic rVSV-mIL12-mGMCSF for Cancer Immunotherapy" International Journal of Molecular Sciences 25, no. 1: 211.
https://doi.org/10.3390/ijms25010211
APA Style
Ryapolova, A., Minskaia, E., Gasanov, N., Moroz, V., Krapivin, B., Egorov, A. D., Laktyushkin, V., Zhuravleva, S., Nagornych, M., Subcheva, E., Malogolovkin, A., Ivanov, R., & Karabelsky, A.
(2024). Development of Recombinant Oncolytic rVSV-mIL12-mGMCSF for Cancer Immunotherapy. International Journal of Molecular Sciences, 25(1), 211.
https://doi.org/10.3390/ijms25010211